Contipro a.s.
CZ-MF-000014702 · Czechia · Dolní Dobrouč
Contipro a.s. is registered in the European database on medical devices as a manufacturer, with 9 devices declared. It was not found in the U.S. FDA device establishment register.
What this manufacturer declares
| Class I | 9 |
|---|
Most frequent device types declared: 35 mg, Hyatoprol 22g, Hyatoprol 50g, Hyiodine 22g, Hyiodine 50g.
Among these devices, 9 are declared sterile, 1 implantable.
Devices declared under this manufacturer
- Fascigel HA
- Hyatoprol 22g
- Hyatoprol 50 g
- Hyatoprol 50g
- Hyiodine 22 g
- Hyiodine 50 g
- Sicalm HA
- Sorelex 10 x 10 cm, 10 pcs
Catalogue references include 150012, 160017.
European nomenclature codes declared: M04041503, P9099, M040412, Q010399.
United States market access
| FDA establishment register | Not found in the FDA register |
|---|---|
| Devices in EUDAMED | 9 |
| Country of registration | Czechia |
⚠️ Not found is not the same as not sold — how this comparison can be wrong.
Device-level evidence
| Devices with a numeric GTIN | 4 |
|---|---|
| Found in the U.S. device database | 0 |
| Share | 0.0 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: Neither register. Contipro a.s. was not found in either the U.S. or the Canadian register.
Notified body certificates
| Certificate | Status | Expiry |
|---|---|---|
2026-MDR/TD-031 | issued | 2028-08-04 |
2026-MDR/QS-031 | issued | 2028-08-04 |
2025-MDR/TD-033 | issued | 2028-08-04 |
2025-MDR/QS-033 | issued | 2028-08-04 |
2023-MDR/TD-016 | issued | 2028-08-04 |
2023-MDR/QS-016 | issued | 2028-08-04 |